NEOSPACE Trial: Neoadjuvant Pembrolizumab-Gemcitabine-cisplatin Followed by Concurrent Pembrolizumab-Chemoradiation and Maintenance Pembrolizumab for Stage IVA Nasopharyngeal Cancer (NPC).
JOURNAL OF CLINICAL ONCOLOGY（2023）
Key words
Cetuximab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined